Background: Despite recommendations from clinical practice guidelines to initiate four drug classes in patients with heart failure (HF) with reduced ejection fraction, information on real-world implementation remains limited. This study evaluated the medications initiated and titrated, the time until the optimal treatment tolerated, pharmacological profiles, patient's adherence, and causes of non-use of guideline directed-medical therapy (GDMT) in a cohort of patients with HF.
Methods: A retrospective cohort study was conducted on patients treated in a heart failure program in Colombia.
Ethylene is a phytohormone that is responsible of fruit and vegetable ripening. TiO has been studied as a possible solution to slowing down unwanted ripening processes, due to its photocatalytic capacity which enables it to remove ethylene. Thus, the objective of this study was to develop nanocomposites based on two types of eco-friendly materials: Mater-Bi (MB) and poly(lactic acid) (PLA) combined with nano-TiO for ethylene removal and to determine their ethylene-removal capacity.
View Article and Find Full Text PDF